4//SEC Filing
Tracon Pharmaceuticals, Inc. 4
Accession 0001209191-15-009754
CIK 0001394319operating
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 3:06 PM ET
Size
13.3 KB
Accession
0001209191-15-009754
Insider Transaction Report
Form 4
Twiford J Rainer
Director
Transactions
- Conversion
Series A Redeemable Convertible Preferred Stock
2015-02-04−1,610,150→ 0 total(indirect: By LLC)→ Common Stock (416,059 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
2015-02-04−934,579→ 0 total(indirect: By LLC)→ Common Stock (241,493 underlying) - Conversion
Common Stock
2015-02-04+657,552→ 657,552 total(indirect: By LLC)
Holdings
- 437,210(indirect: By LLC)
Common Stock
- 93,460(indirect: By LLC)
Common Stock
- 10,029(indirect: By LLC)
Common Stock
- 49,380(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]In connection with the Issuer's initial public offering, the preferred stock automatically converted into shares of the Issuer's common stock at the rate of 1 share of common stock for each 3.87 shares of preferred stock. The preferred stock had no expiration date.
- [F2]The Reporting Person has voting and dispositive power over these shares and disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- [F3]The reporting person's spouse has voting and investment power with respect to the shares held by MCT Investments, LLC.
Documents
Issuer
Tracon Pharmaceuticals, Inc.
CIK 0001394319
Entity typeoperating
Related Parties
1- filerCIK 0001394319
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 3:06 PM ET
- Size
- 13.3 KB